# The Efficacy of Fluticasone Furoate/Vilanterol/Umeclidinium Compared With Vilanterol/Umeclidinium in Reducing Air Trapping and Airway and Blood Cytokine Levels in COPD

> **NCT06474039** · PHASE3 · RECRUITING · sponsor: **Mahidol University** · enrollment: 50 (estimated)

## Conditions studied

- COPD

## Interventions

- **DRUG:** Trelegy or Anoro

## Key facts

- **NCT ID:** NCT06474039
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2026-06
- **Final completion:** 2026-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06474039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06474039, "The Efficacy of Fluticasone Furoate/Vilanterol/Umeclidinium Compared With Vilanterol/Umeclidinium in Reducing Air Trapping and Airway and Blood Cytokine Levels in COPD". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT06474039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*